相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis
Aine C. Murphy et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis
V. S. Conlin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Localizing Central Nervous System Immune Surveillance: Meningeal Antigen-Presenting Cells Activate T Cells during Experimental Autoimmune Encephalomyelitis
Pia Kivisakk et al.
ANNALS OF NEUROLOGY (2009)
Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis
Yossan-Var Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction
Britta Engelhardt et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion
S. A. Hamidi et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Cutting edge: Vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile
Mahesh Yadav et al.
JOURNAL OF IMMUNOLOGY (2008)
The origin and application of experimental autoimmune encephalomyelitis
Alan G. Baxter
NATURE REVIEWS IMMUNOLOGY (2007)
Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testis
Arnaud Lacombe et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene
Sami I. Said et al.
CIRCULATION (2007)
Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis
Wei Sun et al.
INTERNATIONAL IMMUNOLOGY (2006)
Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP
Anthony M. Szema et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis - Down-regulation of inflammatory and autoimmune responses
E Gonzalez-Rey et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis
A Fernandez-Martin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: Focus on VIP and PACAP
C Abad et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
The significance of vasoactive intestinal peptide in immunomodulation
M Delgado et al.
PHARMACOLOGICAL REVIEWS (2004)
Disrupted circadian rhythms in VIP- and PHI-deficient mice
CS Colwell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Lymphocyte regulation of neuropeptide gene expression after neuronal injury
BD Armstrong et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type 11 VIP receptor Transgenic mice
JK Voice et al.
JOURNAL OF IMMUNOLOGY (2003)
VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells
XJ Jiang et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide
JK Voice et al.
REGULATORY PEPTIDES (2002)
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases
M Delgado et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
M Delgado et al.
NATURE MEDICINE (2001)
分享论文
